124 related articles for article (PubMed ID: 25818805)
1. Polo-like kinase 3 is associated with improved overall survival in cholangiocarcinoma.
Juntermanns B; Sydor S; Kaiser GM; Jaradat D; Mertens JC; Sotiropoulos GC; Swoboda S; Neuhaus JP; Meng W; Mathé Z; Baba HA; Canbay A; Paul A; Fingas CD
Liver Int; 2015 Nov; 35(11):2448-57. PubMed ID: 25818805
[TBL] [Abstract][Full Text] [Related]
2. Polo-like kinase 2 is a mediator of hedgehog survival signaling in cholangiocarcinoma.
Fingas CD; Mertens JC; Razumilava N; Sydor S; Bronk SF; Christensen JD; Rizvi SH; Canbay A; Treckmann JW; Paul A; Sirica AE; Gores GJ
Hepatology; 2013 Oct; 58(4):1362-74. PubMed ID: 23703673
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 degradation is an additional pro-apoptotic effect of polo-like kinase inhibition in cholangiocarcinoma cells.
Sydor S; Jafoui S; Wingerter L; Swoboda S; Mertens JC; Gerken G; Canbay A; Paul A; Fingas CD
World J Gastroenterol; 2017 Jun; 23(22):4007-4015. PubMed ID: 28652654
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of polo-like kinases in retinoblastoma: correlation with patient outcome, clinical and histopathological parameters.
Singh L; Pushker N; Sen S; Singh MK; Chauhan FA; Kashyap S
Clin Exp Ophthalmol; 2015 Aug; 43(6):550-7. PubMed ID: 25754767
[TBL] [Abstract][Full Text] [Related]
6. Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma.
Weichert W; Denkert C; Schmidt M; Gekeler V; Wolf G; Köbel M; Dietel M; Hauptmann S
Br J Cancer; 2004 Feb; 90(4):815-21. PubMed ID: 14970859
[TBL] [Abstract][Full Text] [Related]
7. Targeting PDGFR-β in Cholangiocarcinoma.
Fingas CD; Mertens JC; Razumilava N; Bronk SF; Sirica AE; Gores GJ
Liver Int; 2012 Mar; 32(3):400-9. PubMed ID: 22133064
[TBL] [Abstract][Full Text] [Related]
8. Myofibroblast-derived PDGF-BB promotes Hedgehog survival signaling in cholangiocarcinoma cells.
Fingas CD; Bronk SF; Werneburg NW; Mott JL; Guicciardi ME; Cazanave SC; Mertens JC; Sirica AE; Gores GJ
Hepatology; 2011 Dec; 54(6):2076-88. PubMed ID: 22038837
[TBL] [Abstract][Full Text] [Related]
9. BI6727 and GSK461364A, potent PLK1 inhibitors induce G2/M arrest and apoptosis against cholangiocarcinoma cell lines.
Riantana H; Waenphimai O; Mahalapbutr P; Karnchanapandh K; Vaeteewoottacharn K; Wongkham S; Sawanyawisuth K
Pathol Res Pract; 2023 Aug; 248():154678. PubMed ID: 37454493
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.
Xu YF; Yang XQ; Lu XF; Guo S; Liu Y; Iqbal M; Ning SL; Yang H; Suo N; Chen YX
Biochem Biophys Res Commun; 2014 Mar; 446(1):54-60. PubMed ID: 24565842
[TBL] [Abstract][Full Text] [Related]
11. Upregulated Polo-Like Kinase 1 Expression Correlates with Inferior Survival Outcomes in Rectal Cancer.
Tut TG; Lim SH; Dissanayake IU; Descallar J; Chua W; Ng W; de Souza P; Shin JS; Lee CS
PLoS One; 2015; 10(6):e0129313. PubMed ID: 26047016
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of laminin γ2 correlates with poor prognosis and promotes invasion in extrahepatic cholangiocarcinoma.
Liu W; Tian F; Jiang P; Zhao X; Guo F; Li X; Wang S
J Surg Res; 2014 Jan; 186(1):150-6. PubMed ID: 24124977
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of lactate dehydrogenase A in cholangiocarcinoma is correlated with poor prognosis.
Thonsri U; Seubwai W; Waraasawapati S; Sawanyawisuth K; Vaeteewoottacharn K; Boonmars T; Cha'on U
Histol Histopathol; 2017 May; 32(5):503-510. PubMed ID: 27615379
[TBL] [Abstract][Full Text] [Related]
14. Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications.
Weichert W; Kristiansen G; Winzer KJ; Schmidt M; Gekeler V; Noske A; Müller BM; Niesporek S; Dietel M; Denkert C
Virchows Arch; 2005 Apr; 446(4):442-50. PubMed ID: 15785925
[TBL] [Abstract][Full Text] [Related]
15. Dyskerin expression in human fetal, adult and neoplastic intrahepatic bile ducts: correlations with cholangiocarcinoma aggressiveness.
Vasuri F; Rocchi L; Degiovanni A; Giunchi F; Brandi G; Treré D; Montanaro L; D'Errico-Grigioni A
Histopathology; 2015 Jan; 66(2):244-51. PubMed ID: 25367684
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of polo-like kinase 1, 2, 3, and 4 gene expression in mammalian cells and tissues.
Winkles JA; Alberts GF
Oncogene; 2005 Jan; 24(2):260-6. PubMed ID: 15640841
[TBL] [Abstract][Full Text] [Related]
17. SOX4 is associated with poor prognosis in cholangiocarcinoma.
Wang W; Zhang J; Zhan X; Lin T; Yang M; Hu J; Han B; Hu S
Biochem Biophys Res Commun; 2014 Sep; 452(3):614-21. PubMed ID: 25181339
[TBL] [Abstract][Full Text] [Related]
18. PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma.
Loilome W; Juntana S; Namwat N; Bhudhisawasdi V; Puapairoj A; Sripa B; Miwa M; Saya H; Riggins GJ; Yongvanit P
Int J Cancer; 2011 Jul; 129(1):34-44. PubMed ID: 20824711
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase 3 overexpression in human cholangiocarcinoma and promotion of cell growth via apoptosis inhibition.
Yin Y; Zhang M; Dorfman RG; Li Y; Zhao Z; Pan Y; Zhou Q; Huang S; Zhao S; Yao Y; Zou X
Cell Death Dis; 2017 Jun; 8(6):e2856. PubMed ID: 28569784
[TBL] [Abstract][Full Text] [Related]
20. PBK/TOPK in the differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma and its involvement in prognosis of human cholangiocarcinoma.
He F; Yan Q; Fan L; Liu Y; Cui J; Wang J; Wang L; Wang Y; Wang Z; Guo Y; Huang G
Hum Pathol; 2010 Mar; 41(3):415-24. PubMed ID: 19954816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
